Company intelligence / Profile preview

Resilia Pharmaceuticals

Atlanta or unspecified SC location, Georgia or South Carolina, United Statesresiliapharma.com ↗
Ownership
Private
Employees
~50
Development stage
Commercial
01

Overview

Resilia Pharmaceuticals is a privately held specialty pharmaceutical company focused on acquiring and commercializing high-value but underpromoted therapeutics in dermatology. Its lead products include Ecoza® (econazole nitrate) topical foam for tinea pedis, Neosalus® Cream and Lotion for various dermatoses including atopic dermatitis and allergic contact dermatitis, Recedo® Topical Gel for scar management, Neocera® Advanced Cream for skin barrier repair, and Solace® Eczema Cream. The company has relaunched several products that had previously been unavailable due to supply chain disruptions. Clinical results are based on prior regulatory approvals rather than new clinical trials.

Therapeutic areas
Dermatology
Modalities
Small molecules
Industry
Biotech
02

Drug pipeline

4 assets

Solace

Commercial
Indications
Eczema

3 more assets in the full pipeline.

03

Partnerships

Pelle Ventures (for Terbinafine/Solace acquisition/license)

Beyond the preview

Go deeper on Resilia Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resilia Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call